Back to ALNY
STATE STREET CORP ALNY Position History
Alnylam Pharmaceuticals, Inc. • Healthcare
Quarters held
12
Latest value
$1.1B
Q2 2026
Peak value
$1.4B
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $596.9M |
| Q1 2024 | $477M |
| Q2 2024 | $859M |
| Q3 2024 | $953.9M |
| Q4 2024 | $805.5M |
| Q1 2025 | $909M |
| Q2 2025 | $1B |
| Q3 2025 | $1.4B |
| Q4 2025 | $1.3B |
| Q1 2026 | $1.1B |
| Q2 2026 | $1.1B |
| Q2 2026 | $1.1B |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.1B | 3.56M | — | — |
| Q2 2026 | $1.1B | 3.56M | — | — |
| Q1 2026 | $1.1B | 3.32M | — | — |
| Q4 2025 | $1.3B | 3.23M | — | — |
| Q3 2025 | $1.4B | 3.08M | — | — |
| Q2 2025 | $1B | 3.17M | — | — |
| Q1 2025 | $909M | 3.37M | — | — |
| Q4 2024 | $805.5M | 3.42M | — | — |
| Q3 2024 | $953.9M | 3.47M | — | — |
| Q2 2024 | $859M | 3.53M | — | — |
| Q1 2024 | $477M | 3.19M | — | — |
| Q4 2023 | $596.9M | 3.12M | — | — |
Other funds holding ALNY
$5.7B
$4.9B
$4.2B
$3.4B
$1.8B
$1.8B
$1.6B
$1.6B